Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Spondyloarthritis
•
Psoriatic arthritis
•
General Rheumatology
•
Cardiology
•
Cardio-Rheumatology
•
Pericarditis
In a patient with psoriatic arthritis and recurrent pericarditis, would you combine abatacept or other biologics with rilonacept?
Related Questions
What would be the minimum duration of IL-1 therapy you would recommend for chronic pericarditis?
For patients who do not have access to biologic therapies, what are some csDMARD combination pearls or tips that you have that have particular efficacy in different rheumatologic diseases?
In patients with rheumatologic disease, which specific conditions are most strongly associated with mitral valve abnormalities (ex. Libman–Sacks endocarditis, valvulitis, or mitral regurgitation), and how does this influence your approach to screening, monitoring, or treatment?
How do you approach management of recurrent idiopathic pleuropericarditis?
Would you be hesitant to continue a TNF inhibitor in a patient with stable RA and a history of COPD, Cor Pulmonale, severe reduced RVEF, but LVEF 65%?
How do you counsel patients with postural orthostatic tachycardia syndrome (POTS) regarding safe and effective exercise regimens?
How would you approach management of a patient with ankylosing spondylitis who was doing well on tofacitinib, but experienced a STEMI while on therapy?
How do you manage active psoriatic arthritis in a patient with a history of HIV and anal squamous cell carcinoma (post-radiation one year ago), previously treated with apremilast and sulfasalazine but has ongoing disease?
How do you assess the potential role of obesity in driving inflammatory joint symptoms?
How do you approach inflammatory arthralgias without synovitis in a patient with psoriasis?
